BPA for uplizna

Ended Awarded Last action

Contract number
36E79721A0007
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 100% complete
IDV ceiling
$4,348,680.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Blanket Purchase Agreement was awarded by the Department of Veterans Affairs National Acquisition Center to Viela Bio, Inc. for the pharmaceutical Uplizna. With a potential value of $4,348,680, the single award BPA has a period of performance through May 5, 2022 and was awarded on January 12, 2021.

The BPA was established against the Pharmaceuticals and Drugs GSA schedule to provide Uplizna, which is indicated for the treatment of neuromyelitis optica spectrum disorder in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. As no set-aside was used, the award was made on an unrestricted basis. Deliveries are to be made on an as-needed basis to Department of Veterans Affairs medical centers and clinics nationwide over the one year ordering period defined in the BPA.

The purpose of this BPA is to establish streamlined procurement of the neuromyelitis optica spectrum disorder pharmaceutical Uplizna from its manufacturer, Viela Bio, Inc., for Veteran patients treated within the VA healthcare system who have been diagnosed with this rare disease. The contracted products and services will help the VA fulfill its mission to provide world-class medical care to those who have served.

Transactions

Action Obligated Date
Legal Contract Cancellation P00003 · BPA cancellation $0
Supplemental Agreement for work within scope P00002 · 2022 public law pricing updates $0
Exercise an Option P00001 · Exercise an option year for uplizna $0
Original award $0

Quick answers

Who was awarded contract 36E79721A0007?

36E79721A0007 was awarded to Viela Bio, Inc. by National Acquisition Center (Headquarters) on January 12, 2021.

How much is contract 36E79721A0007 worth?

36E79721A0007's own ceiling is $4,348,680.

Who can order from contract 36E79721A0007?

36E79721A0007 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79721A0007 under another contract?

Yes. 36E79721A0007 is a blanket purchase agreement under 36F79721D0020, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79721A0007 competed?

The extent of competition for 36E79721A0007 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV